A-A-0053041A (DM)
25 January 1988
SUPERSEDING
A-A-0053041(DM)
19 June 1987
INTERIM COMMERCIAL ITEM DESCRIPTION
MULTIVITAMIN TABLETS
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Material, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient characteristics:
Shall be coated Multivitamin Tablets having the following formulation within the designated assay limits for the tablets.
|
Vitamin A |
5,000 I.U. |
|
Vitamin D |
400 I.U. |
|
Vitamin E |
15-45 I.U. |
|
Vitamin C (Ascorbic Acid) |
60-90 mg |
|
Folic Acid |
0.4 mg |
|
Vitamin B1 (Thiamine HC1 or Thiamine Mononitrate) |
1.50-3.0 mg |
|
Vitamin B2 (Riboflavin) |
1.70-3.0 mg |
|
Vitamin B3 (Niacin or Niacinamide) |
20-30 mg |
|
Vitamin B6 (Pyridoxine or Pyridoxine HC1) |
2-3 mg |
|
Vitamin B12 (Cyanocobalamin) |
6-9 mcg |
|
Biotin (Optional) |
0.30-0.45 mg |
|
Vitamin B5 (Panthothenic Acid or Calcium Pantothenate) Optional) |
10-15 mg |
Tablets shall assay to contain not less than 120.0 percent and not more than 150.0 percent of the required amount of each labeled vitamin at the time of delivery to the Government, except that Cyanocobalmin (Vitamin B12) and Panthothenic Acid (Bitamin B5) shall assay not less than 150.0 percent and not more than 180.0 percent for each. The assay methods for the
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business